BIOMAT Database Logo BIOMAT Database Logo

Inhibition of dopa decarboxylation by RO4-4602, MK 485 and MK 486 in human liver homogenates. 1972

W H Vogel, and K Mahoney, and T A Hare

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008750 Methyldopa An alpha-2 adrenergic agonist that has both central and peripheral nervous system effects. Its primary clinical use is as an antihypertensive agent. Methyldopate,alpha-Methyldopa,Aldomet,Alphamethyldopa,Apo-Methyldopa,Dopamet,Dopegit,Dopegyt,Dopergit,Hydopa,Meldopa,Nu-Medopa,Sembrina,alpha-Methyl-L-Dopa,Apo Methyldopa,Nu Medopa,alpha Methyl L Dopa,alpha Methyldopa
D002247 Carbon Isotopes Stable carbon atoms that have the same atomic number as the element carbon but differ in atomic weight. C-13 is a stable carbon isotope. Carbon Isotope,Isotope, Carbon,Isotopes, Carbon
D003300 Copper A heavy metal trace element with the atomic symbol Cu, atomic number 29, and atomic weight 63.55. Copper-63,Copper 63
D003653 Decarboxylation The removal of a carboxyl group, usually in the form of carbon dioxide, from a chemical compound. Decarboxylations
D003864 Depression, Chemical The decrease in a measurable parameter of a PHYSIOLOGICAL PROCESS, including cellular, microbial, and plant; immunological, cardiovascular, respiratory, reproductive, urinary, digestive, neural, musculoskeletal, ocular, and skin physiological processes; or METABOLIC PROCESS, including enzymatic and other pharmacological processes, by a drug or other chemical. Chemical Depression,Chemical Depressions,Depressions, Chemical
D004295 Dihydroxyphenylalanine A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific. Dopa,3,4-Dihydroxyphenylalanine,3-Hydroxy-DL-tyrosine,Dihydroxyphenylalanine Hydrochloride, (2:1),beta-Hydroxytyrosine,3 Hydroxy DL tyrosine,3,4 Dihydroxyphenylalanine,beta Hydroxytyrosine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006834 Hydrazines Substituted derivatives of hydrazine (formula H2N-NH2). Hydrazide

Related Publications

W H Vogel, and K Mahoney, and T A Hare
The enzymatic decarboxylation of DOPA in human liver homogenates.
June 1970, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
W H Vogel, and K Mahoney, and T A Hare
Blood-brain barrier to carbidopa (MK-486) and Ro 4-4602, peripheral dopa decarboxylase inhibitors.
May 1973, The Journal of pharmacy and pharmacology,
W H Vogel, and K Mahoney, and T A Hare
Inhibition of hepatic microsomal drug metabolism by the hydrazines Ro 4-4602, MK 486, and procarbazine hydrochloride.
July 1972, Canadian journal of physiology and pharmacology,
W H Vogel, and K Mahoney, and T A Hare
L-dopa with MK 485 for depression.
June 1970, Lancet (London, England),
W H Vogel, and K Mahoney, and T A Hare
L-dopa with MK 485 for depression.
June 1970, Lancet (London, England),
W H Vogel, and K Mahoney, and T A Hare
L-dopa with MK 485 for depression.
June 1970, Lancet (London, England),
W H Vogel, and K Mahoney, and T A Hare
Dose-dependent potentiation or inhibition by Ro4-4602 of 5-HTP hyperthermia in rabbits.
April 1974, The Journal of pharmacy and pharmacology,
W H Vogel, and K Mahoney, and T A Hare
DOPA effects on motility in mice; potentiation by MK 485 and dexchlorpheniramine.
August 1970, Psychopharmacologia,
W H Vogel, and K Mahoney, and T A Hare
[5 years of experience in the treatment of parkinsonism with L-dopa and its combination with Ro4-4602].
January 1976, Neurologia, neurocirugia, psiquiatria,
W H Vogel, and K Mahoney, and T A Hare
Studies on the effects of pyrogallol and the structurally related dopa decarboxylase inhibitor RO4-4602 on acetaldehyde metabolism.
January 1976, Annals of the New York Academy of Sciences,
Copied contents to your clipboard!